These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14503112)

  • 1. Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving total parenteral nutrition.
    Kim H; Son E; Kim J; Choi K; Kim C; Shin W; Suh O
    Am J Health Syst Pharm; 2003 Sep; 60(17):1760-6. PubMed ID: 14503112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose.
    Rosmarin DK; Wardlaw GM; Mirtallo J
    Nutr Clin Pract; 1996 Aug; 11(4):151-6. PubMed ID: 9070016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercholesterolemia and hypertriglyceridemia as risk factors of liver dysfunction in children with inflammation receiving total parenteral nutrition.
    Golucci APBS; Morcillo AM; Hortencio TDR; Ribeiro AF; Nogueira RJN
    Clin Nutr ESPEN; 2018 Feb; 23():148-155. PubMed ID: 29460791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary complications in healthy, intra-abdominally infected, and high-output fistula rats receiving total parenteral nutrition.
    Mok KT
    JPEN J Parenter Enteral Nutr; 1993; 17(5):449-53. PubMed ID: 8289412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of metabolic complications of conventional total parenteral nutrition. A prospective randomized study.
    Meguid MM; Akahoshi MP; Jeffers S; Hayashi RJ; Hammond WG
    Arch Surg; 1984 Nov; 119(11):1294-8. PubMed ID: 6437372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar liver function abnormalities occur in patients receiving glucose-based and lipid-based parenteral nutrition.
    Wagner WH; Lowry AC; Silberman H
    Am J Gastroenterol; 1983 Apr; 78(4):199-202. PubMed ID: 6404158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease.
    Bengoa JM; Hanauer SB; Sitrin MD; Baker AL; Rosenberg IH
    Hepatology; 1985; 5(1):79-84. PubMed ID: 3917969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation.
    Sheean PM; Freels SA; Helton WS; Braunschweig CA
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):656-64. PubMed ID: 16737939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver function tests in patients receiving parenteral nutrition.
    Clarke PJ; Ball MJ; Kettlewell MG
    JPEN J Parenter Enteral Nutr; 1991; 15(1):54-9. PubMed ID: 1901108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients.
    Sheean P; Braunschweig C
    JPEN J Parenter Enteral Nutr; 2006; 30(4):345-50. PubMed ID: 16804133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver test alterations with total parenteral nutrition and nutritional status.
    Leaseburge LA; Winn NJ; Schloerb PR
    JPEN J Parenter Enteral Nutr; 1992; 16(4):348-52. PubMed ID: 1640633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous and intrapulmonary administration of honey solution to healthy sheep: effects on blood sugar, renal and liver function tests, bone marrow function, lipid profile, and carbon tetrachloride-induced liver injury.
    Al-Waili NS
    J Med Food; 2003; 6(3):231-47. PubMed ID: 14585190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronidazole prevention of serum liver enzyme abnormalities during total parenteral nutrition.
    Lambert JR; Thomas SM
    JPEN J Parenter Enteral Nutr; 1985; 9(4):501-3. PubMed ID: 2863398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver function values in adults receiving total parenteral nutrition.
    Lindor KD; Fleming CR; Abrams A; Hirschkorn MA
    JAMA; 1979 Jun; 241(22):2398-400. PubMed ID: 108412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Risk Factors of Total Parenteral Nutrition Induced Hyperglycemia at a Single Institution: Retrospective Study.
    Alchaer M; Khasawneh R; Heuberger R; Hewlings S
    Metab Syndr Relat Disord; 2020 Jun; 18(5):267-273. PubMed ID: 32250718
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels.
    Sax HC; Talamini MA; Brackett K; Fischer JE
    Surgery; 1986 Oct; 100(4):697-704. PubMed ID: 3094186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative total parenteral nutrition in patients with liver disorders.
    Okuno M; Nagayama M; Takai T; Rai A; Nakao S; Kamino K; Umeyama K
    J Surg Res; 1985 Aug; 39(2):93-102. PubMed ID: 3927062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enhanced effect of parenteral nutrition on hepatotoxicity.
    Denno R; Rounds JD; Faris R; Holejko LB; Wilmore DW
    Nutrition; 1996 Jan; 12(1):30-5. PubMed ID: 8838833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepatic enzyme and bilirubin elevations during parenteral nutrition.
    Grant JP; Cox CE; Kleinman LM; Maher MM; Pittman MA; Tangrea JA; Brown JH; Gross E; Beazley RM; Jones RS
    Surg Gynecol Obstet; 1977 Oct; 145(4):573-80. PubMed ID: 408935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver dysfunction and energy source: results of a randomized clinical trial.
    Buchmiller CE; Kleiman-Wexler RL; Ephgrave KS; Booth B; Hensley CE
    JPEN J Parenter Enteral Nutr; 1993; 17(4):301-6. PubMed ID: 8271352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.